Epidemiology of clinical isolates of Candida albicans and their susceptibility to triazoles
- 1 December 2002
- journal article
- Published by Elsevier in International Journal of Antimicrobial Agents
- Vol. 20 (6) , 472-475
- https://doi.org/10.1016/s0924-8579(02)00246-7
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Prospective Study of Candida Species in Patients at a Comprehensive Cancer CenterAntimicrobial Agents and Chemotherapy, 2001
- Prevalence and Antifungal Susceptibility of 442 Candida Isolates from Blood and Other Normally Sterile Sites: Results of a 2-Year (1996 to 1998) Multicenter Surveillance Study in Quebec, CanadaJournal of Clinical Microbiology, 2001
- In Vitro susceptibility of 137 Candida sp. Isolates from HIV positive patients to several antifungal drugsMycopathologia, 2001
- Susceptibility testing of Candida species: comparison of NCCLS microdilution method with Fungitest®Diagnostic Microbiology and Infectious Disease, 2000
- Original ArticlesMycoses, 1999
- The Epidemiology of Hematogenous Candidiasis Caused by Different Candida SpeciesClinical Infectious Diseases, 1997
- Role of Azoles in Antifungal TherapyClinical Infectious Diseases, 1996
- Resistance of Candida species to fluconazoleAntimicrobial Agents and Chemotherapy, 1995
- PUTATIVE VIRULENCE FACTORS OF CANDIDA ALBICANSAnnual Review of Microbiology, 1991
- Fluconazole Penetration into Cerebrospinal Fluid: Implications for Treating Fungal Infections of the Central Nervous SystemThe Journal of Infectious Diseases, 1988